Alkermes plc Stock
Alkermes plc Stock
Alkermes plc took a tumble today and lost -€0.800 (-3.510%).
We see a rather positive sentiment for Alkermes plc with 12 Buy predictions and 2 Sell predictions.
As a result the target price of 34 € shows a very positive potential of 54.55% compared to the current price of 22.0 € for Alkermes plc.
Pros and Cons of Alkermes plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | -3.510% | -2.655% | -10.569% | -14.729% | -12.000% | 20.879% | -14.063% |
| Icon plc | 0.930% | -2.533% | -5.261% | 67.153% | 8.665% | - | - |
| Sage Therapeutics Inc. | -3.520% | 1.448% | -19.076% | -68.390% | -35.200% | -80.196% | - |
| Ironwood Pharmaceuticals | 6.210% | 4.054% | 1.987% | -18.085% | -24.510% | -15.847% | - |
Comments
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Jefferies Financial Group Inc. from $42.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $39.00 price target on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock.
Show more
Ratings data for ALKS provided by MarketBeat